The U.S. pressure infusor market size was estimated at USD 357.11 million in 2025 and is projected to reach USD 532.71 million by 2033, growing at a CAGR of 5.23% from 2026 to 2033. This growth is attributed to the increasing demand for rapid fluid resuscitation in emergency and critical care settings, rising adoption of disposable pressure infusors for infection control, and the growing number of surgical procedures requiring efficient fluid management.
The increasing volume of surgical procedures in the U.S. is a key driver for the pressure infusors industry. According to a study published by ScienceDirect in June 2024, the average total cardiac surgical volume in the U.S. reached 271.5 procedures per 100,000 population per year, reflecting the high procedural burden within hospital settings. Cardiac and other major surgeries often require rapid and controlled fluid or blood administration to maintain hemodynamic stability, particularly during intraoperative blood loss or postoperative complications. As surgical volumes continue to rise, hospitals and surgical centers are expected to increase procurement of essential perioperative devices, including pressure infusor bags, thereby supporting market growth in the U.S.
The growing burden of hemorrhagic conditions in the U.S. is contributing to increased demand for rapid fluid and blood administration devices. According to the American Heart Association, hemorrhagic strokes account for approximately 13% of all stroke cases, representing a significant subset of patients who may require urgent hemodynamic stabilization and blood product transfusion. Management of hemorrhagic stroke and other acute bleeding emergencies often involves rapid volume replacement to maintain cerebral perfusion and systemic stability. As the incidence of such critical bleeding events persists, hospitals and emergency departments continue to rely on pressure infusor bags for immediate and controlled transfusion support, thereby driving growth in the U.S. pressure infusor industry.
Ongoing product innovation and material advancements are further supporting the growth by improving safety, visibility, and clinical efficiency. Manufacturers are increasingly introducing latex-free materials to minimize allergy risks, along with clear or transparent pressure infusor bags that allow clinicians to visually monitor fluid levels, detect air bubbles, and quickly identify leaks without removing the IV bag. Reinforced seams enhance durability, while upgraded pressure gauges and controlled release valves provide more accurate and stable pressure delivery. Moreover, lightweight, high-strength polymer materials improve product longevity while maintaining cost-effectiveness. These innovations enhance usability in emergency and surgical settings, reduce operational risks, and encourage greater adoption across U.S. healthcare facilities.
This product will be delivered within 1-3 business days.
The increasing volume of surgical procedures in the U.S. is a key driver for the pressure infusors industry. According to a study published by ScienceDirect in June 2024, the average total cardiac surgical volume in the U.S. reached 271.5 procedures per 100,000 population per year, reflecting the high procedural burden within hospital settings. Cardiac and other major surgeries often require rapid and controlled fluid or blood administration to maintain hemodynamic stability, particularly during intraoperative blood loss or postoperative complications. As surgical volumes continue to rise, hospitals and surgical centers are expected to increase procurement of essential perioperative devices, including pressure infusor bags, thereby supporting market growth in the U.S.
The growing burden of hemorrhagic conditions in the U.S. is contributing to increased demand for rapid fluid and blood administration devices. According to the American Heart Association, hemorrhagic strokes account for approximately 13% of all stroke cases, representing a significant subset of patients who may require urgent hemodynamic stabilization and blood product transfusion. Management of hemorrhagic stroke and other acute bleeding emergencies often involves rapid volume replacement to maintain cerebral perfusion and systemic stability. As the incidence of such critical bleeding events persists, hospitals and emergency departments continue to rely on pressure infusor bags for immediate and controlled transfusion support, thereby driving growth in the U.S. pressure infusor industry.
Ongoing product innovation and material advancements are further supporting the growth by improving safety, visibility, and clinical efficiency. Manufacturers are increasingly introducing latex-free materials to minimize allergy risks, along with clear or transparent pressure infusor bags that allow clinicians to visually monitor fluid levels, detect air bubbles, and quickly identify leaks without removing the IV bag. Reinforced seams enhance durability, while upgraded pressure gauges and controlled release valves provide more accurate and stable pressure delivery. Moreover, lightweight, high-strength polymer materials improve product longevity while maintaining cost-effectiveness. These innovations enhance usability in emergency and surgical settings, reduce operational risks, and encourage greater adoption across U.S. healthcare facilities.
U.S. Pressure Infusor Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. Pressure infusor market report based on product, capacity, application, and end use.Product Outlook (Revenue, USD Million, 2021-2033)
- Reusable pressure infusors
- Disposable pressure infusors
Capacity Outlook (Revenue, USD Million, 2021-2033)
- 500 mL
- 1000 mL
- 3000 mL
Application Outlook (Revenue, USD Million, 2021-2033)
- Emergency & Critical Care Resuscitation
- Blood and Blood Product Transfusion
- Surgical Fluid Management
- Others
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Infusion Centers
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. U.S. Pressure Infusor Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Pressure Infusor Market: Capacity Estimates & Trend Analysis
Chapter 6. U.S. Pressure Infusor Market: Application Estimates & Trend Analysis
Chapter 7. U.S. Pressure Infusor Market: End Use Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- ICU Medical, Inc.
- Medline
- Merit Medical Systems.
- ASP Global (acquired by Platinum Equity)
- Tapmedic LLC
- Spacelabs Healthcare
- AirLife
- VBM Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 90 |
| Published | March 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 357.11 Million |
| Forecasted Market Value ( USD | $ 532.71 Million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
